Gufic Biosciences Limited (NSE:GUFICBIO)
India · Delayed Price · Currency is INR 386.10
-10.60 (-2.67%)
Jul 22, 2026, 3:29 PM IST
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 39.92 billion as of July 22, 2026. Its market cap has increased by 3.87% in one year.
Market Cap
39.92B
Enterprise Value
43.21B
Revenue
9.44B
Ranking
n/a
PE Ratio
62.17
Stock Price
386.10
ChartMarket Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 39.92B, an increase of 11,078.51%. That is a compound annual growth rate of 20.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 39.92B | 18.22% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 76.33B |
| Aarti Pharmalabs | 64.18B |
| Innova Captab | 55.09B |
| Orchid Pharma | 52.82B |
| RPG Life Sciences | 47.30B |
| Solara Active Pharma Sciences | 27.50B |
| Indoco Remedies | 22.84B |
| Beta Drugs | 22.50B |